AEON BIOPHARMA INC (AEON) Stock Price, Quote, News and Summary
NYSEARCA:AEON - American Stock Exchange - US00791X1000 - Common Stock
AEON Quote and Key Statistics
AEON BIOPHARMA INC
NYSEARCA:AEON (1/17/2025, 8:04:02 PM)
After market: 0.1381 -0.02 (-10.32%)0.154
-0.02 (-9.89%)
AEON Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -116.07% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
AEON Performance and Technical Analysis
AEON Ownership and Analysts
AEON Latest News and Analysis
Top movers in Monday's after hours session
Monday's after hours session: top gainers and losers
Get insights into the top gainers and losers of Friday's after-hours session.
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
Let's take a look at the stocks that are in motion in today's session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Unusual volume stocks in Friday's session
Discover the stocks with unexpected trading volume in today's session on the US markets.
About AEON
Company Profile
AEON Biopharma is a biopharmaceutical company focused on the development of ABP-450, a proprietary 900 kDabotulinum toxin complex, for debilitating medical conditions. The company is headquartered in Newport Beach, California and currently employs 6 full-time employees. The company went IPO on 2021-10-08. The firm is focused on developing botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions. The biologic ingredient in ABP-450 is Clostridium botulinum toxin, type A with a molecular weight of 900 kDa. Its initial development programs for ABP-450 are focused on migraine, cervical dystonia and gastroparesis. Migraine is a neurological condition characterized by recurrent episodes of headaches. The firm is developing ABP-450 for the preventative treatment of migraine, which is inclusive of both chronic migraine and episodic migraine. Cervical dystonia is a neurological condition characterized by involuntary muscle contractions of the neck which may present as spasms, contractions or abnormal posture. Gastroparesis is a gastrointestinal disorder characterized by the slowing or stoppage of movement of food and liquid from the stomach to the small intestine.
Company Info
AEON BIOPHARMA INC
4040 Macarthur Boulevard, Suite 310
Newport Beach CALIFORNIA US
Employees: 5
Company Website: https://www.aeonbiopharma.com/
Investor Relations: https://investors.aeonbiopharma.com/overview/default.aspx
Phone: 19492844555.0